nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—Dacarbazine—sarcoma	0.0956	0.228	CbGbCtD
Maprotiline—ABCB1—Dactinomycin—sarcoma	0.0725	0.173	CbGbCtD
Maprotiline—ABCB1—Mitoxantrone—sarcoma	0.0649	0.155	CbGbCtD
Maprotiline—CYP1A2—Etoposide—sarcoma	0.0468	0.112	CbGbCtD
Maprotiline—ABCB1—Vincristine—sarcoma	0.0446	0.106	CbGbCtD
Maprotiline—ABCB1—Etoposide—sarcoma	0.0409	0.0975	CbGbCtD
Maprotiline—ABCB1—Doxorubicin—sarcoma	0.0279	0.0665	CbGbCtD
Maprotiline—CYP2D6—Doxorubicin—sarcoma	0.0263	0.0627	CbGbCtD
Maprotiline—CHRM3—muscle of abdomen—sarcoma	0.0121	0.144	CbGeAlD
Maprotiline—HTR7—pulmonary artery—sarcoma	0.00975	0.116	CbGeAlD
Maprotiline—HTR2A—pulmonary artery—sarcoma	0.00608	0.0726	CbGeAlD
Maprotiline—HTR2A—hindlimb—sarcoma	0.00368	0.0439	CbGeAlD
Maprotiline—HTR2A—appendage—sarcoma	0.00315	0.0376	CbGeAlD
Maprotiline—HTR7—endothelium—sarcoma	0.00305	0.0364	CbGeAlD
Maprotiline—CHRM5—skin of body—sarcoma	0.00245	0.0292	CbGeAlD
Maprotiline—ORM1—hematopoietic system—sarcoma	0.00207	0.0247	CbGeAlD
Maprotiline—CHRM4—testis—sarcoma	0.00197	0.0236	CbGeAlD
Maprotiline—SLC6A3—hematopoietic system—sarcoma	0.00193	0.023	CbGeAlD
Maprotiline—HTR2A—endothelium—sarcoma	0.0019	0.0227	CbGeAlD
Maprotiline—HTR7—hematopoietic system—sarcoma	0.0015	0.0179	CbGeAlD
Maprotiline—HTR7—connective tissue—sarcoma	0.00144	0.0172	CbGeAlD
Maprotiline—CHRM3—smooth muscle tissue—sarcoma	0.00139	0.0166	CbGeAlD
Maprotiline—ORM1—bone marrow—sarcoma	0.00133	0.0159	CbGeAlD
Maprotiline—HTR7—smooth muscle tissue—sarcoma	0.00132	0.0158	CbGeAlD
Maprotiline—HRH1—myometrium—sarcoma	0.0013	0.0156	CbGeAlD
Maprotiline—CYP1A2—hematopoietic system—sarcoma	0.0012	0.0143	CbGeAlD
Maprotiline—HRH1—hematopoietic system—sarcoma	0.00112	0.0134	CbGeAlD
Maprotiline—HRH1—connective tissue—sarcoma	0.00108	0.0129	CbGeAlD
Maprotiline—ORM1—liver—sarcoma	0.00107	0.0128	CbGeAlD
Maprotiline—SLC6A3—testis—sarcoma	0.00106	0.0126	CbGeAlD
Maprotiline—HTR2A—embryo—sarcoma	0.00105	0.0125	CbGeAlD
Maprotiline—HTR7—tendon—sarcoma	0.000992	0.0118	CbGeAlD
Maprotiline—HRH1—smooth muscle tissue—sarcoma	0.000986	0.0118	CbGeAlD
Maprotiline—Increased appetite—Doxorubicin—sarcoma	0.000958	0.00193	CcSEcCtD
Maprotiline—Menopausal symptoms—Doxorubicin—sarcoma	0.000954	0.00192	CcSEcCtD
Maprotiline—Insomnia—Vincristine—sarcoma	0.000953	0.00192	CcSEcCtD
Maprotiline—Paraesthesia—Vincristine—sarcoma	0.000946	0.0019	CcSEcCtD
Maprotiline—Urticaria—Thiotepa—sarcoma	0.000944	0.0019	CcSEcCtD
Maprotiline—Abdominal pain—Thiotepa—sarcoma	0.000939	0.00189	CcSEcCtD
Maprotiline—Body temperature increased—Thiotepa—sarcoma	0.000939	0.00189	CcSEcCtD
Maprotiline—Leukopenia—Etoposide—sarcoma	0.000936	0.00188	CcSEcCtD
Maprotiline—HTR2A—hematopoietic system—sarcoma	0.000935	0.0112	CbGeAlD
Maprotiline—Purpura—Doxorubicin—sarcoma	0.000934	0.00188	CcSEcCtD
Maprotiline—Body temperature increased—Dactinomycin—sarcoma	0.000932	0.00188	CcSEcCtD
Maprotiline—Abdominal pain—Dactinomycin—sarcoma	0.000932	0.00188	CcSEcCtD
Maprotiline—Paraesthesia—Mitoxantrone—sarcoma	0.000921	0.00185	CcSEcCtD
Maprotiline—Loss of consciousness—Etoposide—sarcoma	0.000919	0.00185	CcSEcCtD
Maprotiline—Cerebrovascular accident—Doxorubicin—sarcoma	0.000919	0.00185	CcSEcCtD
Maprotiline—Ataxia—Epirubicin—sarcoma	0.000915	0.00184	CcSEcCtD
Maprotiline—Somnolence—Mitoxantrone—sarcoma	0.000912	0.00184	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Vincristine—sarcoma	0.000909	0.00183	CcSEcCtD
Maprotiline—Fatigue—Vincristine—sarcoma	0.000908	0.00183	CcSEcCtD
Maprotiline—Convulsion—Etoposide—sarcoma	0.000906	0.00182	CcSEcCtD
Maprotiline—Dyspepsia—Mitoxantrone—sarcoma	0.000903	0.00182	CcSEcCtD
Maprotiline—Hypertension—Etoposide—sarcoma	0.000903	0.00182	CcSEcCtD
Maprotiline—Constipation—Vincristine—sarcoma	0.000901	0.00181	CcSEcCtD
Maprotiline—Osteoarthritis—Doxorubicin—sarcoma	0.0009	0.00181	CcSEcCtD
Maprotiline—HTR2A—connective tissue—sarcoma	0.0009	0.0107	CbGeAlD
Maprotiline—Liver function test abnormal—Epirubicin—sarcoma	0.000898	0.00181	CcSEcCtD
Maprotiline—Orthostatic hypotension—Epirubicin—sarcoma	0.000889	0.00179	CcSEcCtD
Maprotiline—Fatigue—Mitoxantrone—sarcoma	0.000884	0.00178	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000884	0.00178	CcSEcCtD
Maprotiline—Breast disorder—Epirubicin—sarcoma	0.000879	0.00177	CcSEcCtD
Maprotiline—Constipation—Mitoxantrone—sarcoma	0.000877	0.00177	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000876	0.00176	CcSEcCtD
Maprotiline—CHRM3—testis—sarcoma	0.000863	0.0103	CbGeAlD
Maprotiline—Gastrointestinal pain—Vincristine—sarcoma	0.000861	0.00173	CcSEcCtD
Maprotiline—Confusional state—Etoposide—sarcoma	0.00086	0.00173	CcSEcCtD
Maprotiline—Muscular weakness—Epirubicin—sarcoma	0.000858	0.00173	CcSEcCtD
Maprotiline—SLC6A2—testis—sarcoma	0.000852	0.0102	CbGeAlD
Maprotiline—Asthenia—Thiotepa—sarcoma	0.000852	0.00172	CcSEcCtD
Maprotiline—CYP2D6—hematopoietic system—sarcoma	0.000852	0.0102	CbGeAlD
Maprotiline—Infection—Etoposide—sarcoma	0.000848	0.00171	CcSEcCtD
Maprotiline—Ataxia—Doxorubicin—sarcoma	0.000847	0.0017	CcSEcCtD
Maprotiline—Asthenia—Dactinomycin—sarcoma	0.000846	0.0017	CcSEcCtD
Maprotiline—Feeling abnormal—Mitoxantrone—sarcoma	0.000845	0.0017	CcSEcCtD
Maprotiline—Dysphagia—Epirubicin—sarcoma	0.000841	0.00169	CcSEcCtD
Maprotiline—Pruritus—Thiotepa—sarcoma	0.00084	0.00169	CcSEcCtD
Maprotiline—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000839	0.00169	CcSEcCtD
Maprotiline—Thrombocytopenia—Etoposide—sarcoma	0.000835	0.00168	CcSEcCtD
Maprotiline—Tachycardia—Etoposide—sarcoma	0.000833	0.00168	CcSEcCtD
Maprotiline—Eosinophilia—Epirubicin—sarcoma	0.000833	0.00168	CcSEcCtD
Maprotiline—Abdominal pain—Vincristine—sarcoma	0.000833	0.00168	CcSEcCtD
Maprotiline—Body temperature increased—Vincristine—sarcoma	0.000833	0.00168	CcSEcCtD
Maprotiline—Liver function test abnormal—Doxorubicin—sarcoma	0.000831	0.00167	CcSEcCtD
Maprotiline—Skin disorder—Etoposide—sarcoma	0.000829	0.00167	CcSEcCtD
Maprotiline—Hyperhidrosis—Etoposide—sarcoma	0.000825	0.00166	CcSEcCtD
Maprotiline—ORM1—lymph node—sarcoma	0.000824	0.00983	CbGeAlD
Maprotiline—HTR2A—smooth muscle tissue—sarcoma	0.000823	0.00983	CbGeAlD
Maprotiline—Orthostatic hypotension—Doxorubicin—sarcoma	0.000822	0.00166	CcSEcCtD
Maprotiline—HTR7—testis—sarcoma	0.000821	0.00981	CbGeAlD
Maprotiline—Urticaria—Mitoxantrone—sarcoma	0.000815	0.00164	CcSEcCtD
Maprotiline—Breast disorder—Doxorubicin—sarcoma	0.000814	0.00164	CcSEcCtD
Maprotiline—Diarrhoea—Thiotepa—sarcoma	0.000813	0.00164	CcSEcCtD
Maprotiline—Body temperature increased—Mitoxantrone—sarcoma	0.000811	0.00163	CcSEcCtD
Maprotiline—Abdominal pain—Mitoxantrone—sarcoma	0.000811	0.00163	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000811	0.00163	CcSEcCtD
Maprotiline—Diarrhoea—Dactinomycin—sarcoma	0.000807	0.00162	CcSEcCtD
Maprotiline—Pancytopenia—Epirubicin—sarcoma	0.000799	0.00161	CcSEcCtD
Maprotiline—Hypotension—Etoposide—sarcoma	0.000797	0.0016	CcSEcCtD
Maprotiline—Muscular weakness—Doxorubicin—sarcoma	0.000794	0.0016	CcSEcCtD
Maprotiline—Dizziness—Thiotepa—sarcoma	0.000785	0.00158	CcSEcCtD
Maprotiline—Dysphagia—Doxorubicin—sarcoma	0.000778	0.00157	CcSEcCtD
Maprotiline—Pollakiuria—Epirubicin—sarcoma	0.000777	0.00156	CcSEcCtD
Maprotiline—DRD2—testis—sarcoma	0.000777	0.00927	CbGeAlD
Maprotiline—HTR7—liver—sarcoma	0.000777	0.00927	CbGeAlD
Maprotiline—Eosinophilia—Doxorubicin—sarcoma	0.00077	0.00155	CcSEcCtD
Maprotiline—Photosensitivity reaction—Epirubicin—sarcoma	0.000768	0.00155	CcSEcCtD
Maprotiline—Paraesthesia—Etoposide—sarcoma	0.000766	0.00154	CcSEcCtD
Maprotiline—Weight increased—Epirubicin—sarcoma	0.000765	0.00154	CcSEcCtD
Maprotiline—Weight decreased—Epirubicin—sarcoma	0.000761	0.00153	CcSEcCtD
Maprotiline—Somnolence—Etoposide—sarcoma	0.000758	0.00153	CcSEcCtD
Maprotiline—Asthenia—Vincristine—sarcoma	0.000756	0.00152	CcSEcCtD
Maprotiline—Vomiting—Thiotepa—sarcoma	0.000755	0.00152	CcSEcCtD
Maprotiline—Infestation—Epirubicin—sarcoma	0.00075	0.00151	CcSEcCtD
Maprotiline—Infestation NOS—Epirubicin—sarcoma	0.00075	0.00151	CcSEcCtD
Maprotiline—Drowsiness—Epirubicin—sarcoma	0.00075	0.00151	CcSEcCtD
Maprotiline—Vomiting—Dactinomycin—sarcoma	0.00075	0.00151	CcSEcCtD
Maprotiline—Rash—Thiotepa—sarcoma	0.000749	0.00151	CcSEcCtD
Maprotiline—Dermatitis—Thiotepa—sarcoma	0.000748	0.00151	CcSEcCtD
Maprotiline—Headache—Thiotepa—sarcoma	0.000744	0.0015	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000743	0.0015	CcSEcCtD
Maprotiline—Rash—Dactinomycin—sarcoma	0.000743	0.0015	CcSEcCtD
Maprotiline—HRH1—tendon—sarcoma	0.000741	0.00884	CbGeAlD
Maprotiline—Pancytopenia—Doxorubicin—sarcoma	0.000739	0.00149	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Etoposide—sarcoma	0.000737	0.00148	CcSEcCtD
Maprotiline—Asthenia—Mitoxantrone—sarcoma	0.000736	0.00148	CcSEcCtD
Maprotiline—Fatigue—Etoposide—sarcoma	0.000736	0.00148	CcSEcCtD
Maprotiline—Neuropathy peripheral—Epirubicin—sarcoma	0.000735	0.00148	CcSEcCtD
Maprotiline—Stomatitis—Epirubicin—sarcoma	0.000731	0.00147	CcSEcCtD
Maprotiline—Jaundice—Epirubicin—sarcoma	0.000731	0.00147	CcSEcCtD
Maprotiline—Constipation—Etoposide—sarcoma	0.00073	0.00147	CcSEcCtD
Maprotiline—Diarrhoea—Vincristine—sarcoma	0.000721	0.00145	CcSEcCtD
Maprotiline—Pollakiuria—Doxorubicin—sarcoma	0.000719	0.00145	CcSEcCtD
Maprotiline—ABCB1—myometrium—sarcoma	0.000713	0.00852	CbGeAlD
Maprotiline—Photosensitivity reaction—Doxorubicin—sarcoma	0.00071	0.00143	CcSEcCtD
Maprotiline—Hepatobiliary disease—Epirubicin—sarcoma	0.000709	0.00143	CcSEcCtD
Maprotiline—Weight increased—Doxorubicin—sarcoma	0.000708	0.00143	CcSEcCtD
Maprotiline—Nausea—Thiotepa—sarcoma	0.000706	0.00142	CcSEcCtD
Maprotiline—Weight decreased—Doxorubicin—sarcoma	0.000704	0.00142	CcSEcCtD
Maprotiline—Feeling abnormal—Etoposide—sarcoma	0.000703	0.00142	CcSEcCtD
Maprotiline—Diarrhoea—Mitoxantrone—sarcoma	0.000702	0.00141	CcSEcCtD
Maprotiline—Nausea—Dactinomycin—sarcoma	0.0007	0.00141	CcSEcCtD
Maprotiline—Agranulocytosis—Epirubicin—sarcoma	0.0007	0.00141	CcSEcCtD
Maprotiline—Gastrointestinal pain—Etoposide—sarcoma	0.000698	0.0014	CcSEcCtD
Maprotiline—Dizziness—Vincristine—sarcoma	0.000696	0.0014	CcSEcCtD
Maprotiline—Infestation NOS—Doxorubicin—sarcoma	0.000694	0.0014	CcSEcCtD
Maprotiline—Infestation—Doxorubicin—sarcoma	0.000694	0.0014	CcSEcCtD
Maprotiline—Drowsiness—Doxorubicin—sarcoma	0.000694	0.0014	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000688	0.00138	CcSEcCtD
Maprotiline—ABCB1—embryo—sarcoma	0.000686	0.00819	CbGeAlD
Maprotiline—Neuropathy peripheral—Doxorubicin—sarcoma	0.00068	0.00137	CcSEcCtD
Maprotiline—Urticaria—Etoposide—sarcoma	0.000678	0.00136	CcSEcCtD
Maprotiline—Stomatitis—Doxorubicin—sarcoma	0.000676	0.00136	CcSEcCtD
Maprotiline—Jaundice—Doxorubicin—sarcoma	0.000676	0.00136	CcSEcCtD
Maprotiline—Abdominal pain—Etoposide—sarcoma	0.000674	0.00136	CcSEcCtD
Maprotiline—Body temperature increased—Etoposide—sarcoma	0.000674	0.00136	CcSEcCtD
Maprotiline—Hepatitis—Epirubicin—sarcoma	0.000673	0.00136	CcSEcCtD
Maprotiline—Hypoaesthesia—Epirubicin—sarcoma	0.00067	0.00135	CcSEcCtD
Maprotiline—Vomiting—Vincristine—sarcoma	0.00067	0.00135	CcSEcCtD
Maprotiline—Urinary tract disorder—Epirubicin—sarcoma	0.000665	0.00134	CcSEcCtD
Maprotiline—Rash—Vincristine—sarcoma	0.000664	0.00134	CcSEcCtD
Maprotiline—Dermatitis—Vincristine—sarcoma	0.000663	0.00134	CcSEcCtD
Maprotiline—Urethral disorder—Epirubicin—sarcoma	0.00066	0.00133	CcSEcCtD
Maprotiline—Headache—Vincristine—sarcoma	0.00066	0.00133	CcSEcCtD
Maprotiline—Hepatobiliary disease—Doxorubicin—sarcoma	0.000656	0.00132	CcSEcCtD
Maprotiline—Vomiting—Mitoxantrone—sarcoma	0.000652	0.00131	CcSEcCtD
Maprotiline—Agranulocytosis—Doxorubicin—sarcoma	0.000647	0.0013	CcSEcCtD
Maprotiline—Rash—Mitoxantrone—sarcoma	0.000647	0.0013	CcSEcCtD
Maprotiline—Dermatitis—Mitoxantrone—sarcoma	0.000646	0.0013	CcSEcCtD
Maprotiline—ABCB1—seminal vesicle—sarcoma	0.000645	0.00769	CbGeAlD
Maprotiline—Headache—Mitoxantrone—sarcoma	0.000643	0.00129	CcSEcCtD
Maprotiline—Erythema multiforme—Epirubicin—sarcoma	0.000636	0.00128	CcSEcCtD
Maprotiline—Eye disorder—Epirubicin—sarcoma	0.000629	0.00127	CcSEcCtD
Maprotiline—Tinnitus—Epirubicin—sarcoma	0.000628	0.00126	CcSEcCtD
Maprotiline—Nausea—Vincristine—sarcoma	0.000626	0.00126	CcSEcCtD
Maprotiline—Flushing—Epirubicin—sarcoma	0.000625	0.00126	CcSEcCtD
Maprotiline—Cardiac disorder—Epirubicin—sarcoma	0.000625	0.00126	CcSEcCtD
Maprotiline—Hepatitis—Doxorubicin—sarcoma	0.000623	0.00125	CcSEcCtD
Maprotiline—Hypoaesthesia—Doxorubicin—sarcoma	0.00062	0.00125	CcSEcCtD
Maprotiline—CYP1A2—liver—sarcoma	0.000619	0.00739	CbGeAlD
Maprotiline—HTR2A—tendon—sarcoma	0.000619	0.00738	CbGeAlD
Maprotiline—SLC6A2—lymph node—sarcoma	0.000618	0.00737	CbGeAlD
Maprotiline—Urinary tract disorder—Doxorubicin—sarcoma	0.000615	0.00124	CcSEcCtD
Maprotiline—HRH1—testis—sarcoma	0.000613	0.00732	CbGeAlD
Maprotiline—ABCB1—hematopoietic system—sarcoma	0.000613	0.00731	CbGeAlD
Maprotiline—Asthenia—Etoposide—sarcoma	0.000612	0.00123	CcSEcCtD
Maprotiline—Angiopathy—Epirubicin—sarcoma	0.000611	0.00123	CcSEcCtD
Maprotiline—Urethral disorder—Doxorubicin—sarcoma	0.000611	0.00123	CcSEcCtD
Maprotiline—Nausea—Mitoxantrone—sarcoma	0.000609	0.00123	CcSEcCtD
Maprotiline—Mediastinal disorder—Epirubicin—sarcoma	0.000607	0.00122	CcSEcCtD
Maprotiline—Pruritus—Etoposide—sarcoma	0.000604	0.00122	CcSEcCtD
Maprotiline—Arrhythmia—Epirubicin—sarcoma	0.000601	0.00121	CcSEcCtD
Maprotiline—Alopecia—Epirubicin—sarcoma	0.000595	0.0012	CcSEcCtD
Maprotiline—Erythema multiforme—Doxorubicin—sarcoma	0.000589	0.00119	CcSEcCtD
Maprotiline—Malnutrition—Epirubicin—sarcoma	0.000586	0.00118	CcSEcCtD
Maprotiline—Diarrhoea—Etoposide—sarcoma	0.000584	0.00118	CcSEcCtD
Maprotiline—Eye disorder—Doxorubicin—sarcoma	0.000582	0.00117	CcSEcCtD
Maprotiline—Tinnitus—Doxorubicin—sarcoma	0.000581	0.00117	CcSEcCtD
Maprotiline—Flushing—Doxorubicin—sarcoma	0.000578	0.00116	CcSEcCtD
Maprotiline—Cardiac disorder—Doxorubicin—sarcoma	0.000578	0.00116	CcSEcCtD
Maprotiline—Tension—Epirubicin—sarcoma	0.000575	0.00116	CcSEcCtD
Maprotiline—Dysgeusia—Epirubicin—sarcoma	0.000574	0.00116	CcSEcCtD
Maprotiline—Nervousness—Epirubicin—sarcoma	0.000569	0.00115	CcSEcCtD
Maprotiline—Angiopathy—Doxorubicin—sarcoma	0.000565	0.00114	CcSEcCtD
Maprotiline—Dizziness—Etoposide—sarcoma	0.000564	0.00114	CcSEcCtD
Maprotiline—Mediastinal disorder—Doxorubicin—sarcoma	0.000561	0.00113	CcSEcCtD
Maprotiline—Arrhythmia—Doxorubicin—sarcoma	0.000556	0.00112	CcSEcCtD
Maprotiline—Vision blurred—Epirubicin—sarcoma	0.000552	0.00111	CcSEcCtD
Maprotiline—Alopecia—Doxorubicin—sarcoma	0.00055	0.00111	CcSEcCtD
Maprotiline—Vomiting—Etoposide—sarcoma	0.000542	0.00109	CcSEcCtD
Maprotiline—Malnutrition—Doxorubicin—sarcoma	0.000542	0.00109	CcSEcCtD
Maprotiline—Agitation—Epirubicin—sarcoma	0.000539	0.00108	CcSEcCtD
Maprotiline—Rash—Etoposide—sarcoma	0.000538	0.00108	CcSEcCtD
Maprotiline—Dermatitis—Etoposide—sarcoma	0.000537	0.00108	CcSEcCtD
Maprotiline—Headache—Etoposide—sarcoma	0.000534	0.00108	CcSEcCtD
Maprotiline—Tension—Doxorubicin—sarcoma	0.000532	0.00107	CcSEcCtD
Maprotiline—Dysgeusia—Doxorubicin—sarcoma	0.000531	0.00107	CcSEcCtD
Maprotiline—Nervousness—Doxorubicin—sarcoma	0.000527	0.00106	CcSEcCtD
Maprotiline—Syncope—Epirubicin—sarcoma	0.000526	0.00106	CcSEcCtD
Maprotiline—Leukopenia—Epirubicin—sarcoma	0.000525	0.00106	CcSEcCtD
Maprotiline—Palpitations—Epirubicin—sarcoma	0.000518	0.00104	CcSEcCtD
Maprotiline—Loss of consciousness—Epirubicin—sarcoma	0.000515	0.00104	CcSEcCtD
Maprotiline—HTR2A—testis—sarcoma	0.000512	0.00611	CbGeAlD
Maprotiline—Vision blurred—Doxorubicin—sarcoma	0.000511	0.00103	CcSEcCtD
Maprotiline—Convulsion—Epirubicin—sarcoma	0.000508	0.00102	CcSEcCtD
Maprotiline—Nausea—Etoposide—sarcoma	0.000507	0.00102	CcSEcCtD
Maprotiline—Hypertension—Epirubicin—sarcoma	0.000506	0.00102	CcSEcCtD
Maprotiline—Agitation—Doxorubicin—sarcoma	0.000498	0.001	CcSEcCtD
Maprotiline—Anxiety—Epirubicin—sarcoma	0.000497	0.001	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000495	0.000997	CcSEcCtD
Maprotiline—Dry mouth—Epirubicin—sarcoma	0.000488	0.000982	CcSEcCtD
Maprotiline—Syncope—Doxorubicin—sarcoma	0.000486	0.000979	CcSEcCtD
Maprotiline—Leukopenia—Doxorubicin—sarcoma	0.000485	0.000977	CcSEcCtD
Maprotiline—HTR2A—liver—sarcoma	0.000484	0.00578	CbGeAlD
Maprotiline—Confusional state—Epirubicin—sarcoma	0.000482	0.000971	CcSEcCtD
Maprotiline—Palpitations—Doxorubicin—sarcoma	0.000479	0.000965	CcSEcCtD
Maprotiline—Oedema—Epirubicin—sarcoma	0.000478	0.000963	CcSEcCtD
Maprotiline—Loss of consciousness—Doxorubicin—sarcoma	0.000477	0.000959	CcSEcCtD
Maprotiline—Infection—Epirubicin—sarcoma	0.000475	0.000956	CcSEcCtD
Maprotiline—Shock—Epirubicin—sarcoma	0.000471	0.000947	CcSEcCtD
Maprotiline—Convulsion—Doxorubicin—sarcoma	0.00047	0.000946	CcSEcCtD
Maprotiline—Nervous system disorder—Epirubicin—sarcoma	0.000469	0.000944	CcSEcCtD
Maprotiline—Thrombocytopenia—Epirubicin—sarcoma	0.000468	0.000943	CcSEcCtD
Maprotiline—Hypertension—Doxorubicin—sarcoma	0.000468	0.000942	CcSEcCtD
Maprotiline—Tachycardia—Epirubicin—sarcoma	0.000467	0.00094	CcSEcCtD
Maprotiline—CYP2D6—testis—sarcoma	0.000467	0.00557	CbGeAlD
Maprotiline—Skin disorder—Epirubicin—sarcoma	0.000465	0.000935	CcSEcCtD
Maprotiline—ABCB1—uterus—sarcoma	0.000463	0.00552	CbGeAlD
Maprotiline—Hyperhidrosis—Epirubicin—sarcoma	0.000462	0.000931	CcSEcCtD
Maprotiline—Anxiety—Doxorubicin—sarcoma	0.00046	0.000926	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000458	0.000923	CcSEcCtD
Maprotiline—Dry mouth—Doxorubicin—sarcoma	0.000451	0.000909	CcSEcCtD
Maprotiline—Hypotension—Epirubicin—sarcoma	0.000447	0.0009	CcSEcCtD
Maprotiline—Confusional state—Doxorubicin—sarcoma	0.000446	0.000898	CcSEcCtD
Maprotiline—HRH1—lymph node—sarcoma	0.000445	0.00531	CbGeAlD
Maprotiline—Oedema—Doxorubicin—sarcoma	0.000443	0.000891	CcSEcCtD
Maprotiline—CYP2D6—liver—sarcoma	0.000441	0.00527	CbGeAlD
Maprotiline—Infection—Doxorubicin—sarcoma	0.00044	0.000885	CcSEcCtD
Maprotiline—Shock—Doxorubicin—sarcoma	0.000435	0.000876	CcSEcCtD
Maprotiline—Nervous system disorder—Doxorubicin—sarcoma	0.000434	0.000874	CcSEcCtD
Maprotiline—Thrombocytopenia—Doxorubicin—sarcoma	0.000433	0.000872	CcSEcCtD
Maprotiline—Insomnia—Epirubicin—sarcoma	0.000433	0.000871	CcSEcCtD
Maprotiline—Tachycardia—Doxorubicin—sarcoma	0.000432	0.000869	CcSEcCtD
Maprotiline—ABCB1—lymphoid tissue—sarcoma	0.000431	0.00515	CbGeAlD
Maprotiline—Skin disorder—Doxorubicin—sarcoma	0.00043	0.000865	CcSEcCtD
Maprotiline—Paraesthesia—Epirubicin—sarcoma	0.000429	0.000864	CcSEcCtD
Maprotiline—Hyperhidrosis—Doxorubicin—sarcoma	0.000428	0.000861	CcSEcCtD
Maprotiline—Somnolence—Epirubicin—sarcoma	0.000425	0.000856	CcSEcCtD
Maprotiline—Dyspepsia—Epirubicin—sarcoma	0.000421	0.000847	CcSEcCtD
Maprotiline—Hypotension—Doxorubicin—sarcoma	0.000414	0.000832	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Epirubicin—sarcoma	0.000413	0.000831	CcSEcCtD
Maprotiline—Fatigue—Epirubicin—sarcoma	0.000412	0.00083	CcSEcCtD
Maprotiline—Constipation—Epirubicin—sarcoma	0.000409	0.000823	CcSEcCtD
Maprotiline—Insomnia—Doxorubicin—sarcoma	0.0004	0.000806	CcSEcCtD
Maprotiline—Paraesthesia—Doxorubicin—sarcoma	0.000397	0.0008	CcSEcCtD
Maprotiline—Feeling abnormal—Epirubicin—sarcoma	0.000394	0.000793	CcSEcCtD
Maprotiline—Somnolence—Doxorubicin—sarcoma	0.000393	0.000792	CcSEcCtD
Maprotiline—ABCB1—bone marrow—sarcoma	0.000393	0.00469	CbGeAlD
Maprotiline—Gastrointestinal pain—Epirubicin—sarcoma	0.000391	0.000787	CcSEcCtD
Maprotiline—Dyspepsia—Doxorubicin—sarcoma	0.00039	0.000784	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000382	0.000769	CcSEcCtD
Maprotiline—Fatigue—Doxorubicin—sarcoma	0.000382	0.000768	CcSEcCtD
Maprotiline—Urticaria—Epirubicin—sarcoma	0.00038	0.000765	CcSEcCtD
Maprotiline—Constipation—Doxorubicin—sarcoma	0.000378	0.000762	CcSEcCtD
Maprotiline—Abdominal pain—Epirubicin—sarcoma	0.000378	0.000761	CcSEcCtD
Maprotiline—Body temperature increased—Epirubicin—sarcoma	0.000378	0.000761	CcSEcCtD
Maprotiline—Feeling abnormal—Doxorubicin—sarcoma	0.000365	0.000734	CcSEcCtD
Maprotiline—Gastrointestinal pain—Doxorubicin—sarcoma	0.000362	0.000728	CcSEcCtD
Maprotiline—Urticaria—Doxorubicin—sarcoma	0.000352	0.000708	CcSEcCtD
Maprotiline—Body temperature increased—Doxorubicin—sarcoma	0.00035	0.000704	CcSEcCtD
Maprotiline—Abdominal pain—Doxorubicin—sarcoma	0.00035	0.000704	CcSEcCtD
Maprotiline—Asthenia—Epirubicin—sarcoma	0.000343	0.000691	CcSEcCtD
Maprotiline—Pruritus—Epirubicin—sarcoma	0.000338	0.000681	CcSEcCtD
Maprotiline—ABCB1—testis—sarcoma	0.000336	0.00401	CbGeAlD
Maprotiline—Diarrhoea—Epirubicin—sarcoma	0.000327	0.000659	CcSEcCtD
Maprotiline—Asthenia—Doxorubicin—sarcoma	0.000317	0.000639	CcSEcCtD
Maprotiline—ABCB1—liver—sarcoma	0.000317	0.00379	CbGeAlD
Maprotiline—Dizziness—Epirubicin—sarcoma	0.000316	0.000637	CcSEcCtD
Maprotiline—Pruritus—Doxorubicin—sarcoma	0.000313	0.00063	CcSEcCtD
Maprotiline—Vomiting—Epirubicin—sarcoma	0.000304	0.000612	CcSEcCtD
Maprotiline—Diarrhoea—Doxorubicin—sarcoma	0.000303	0.000609	CcSEcCtD
Maprotiline—Rash—Epirubicin—sarcoma	0.000302	0.000607	CcSEcCtD
Maprotiline—Dermatitis—Epirubicin—sarcoma	0.000301	0.000606	CcSEcCtD
Maprotiline—Headache—Epirubicin—sarcoma	0.0003	0.000603	CcSEcCtD
Maprotiline—Dizziness—Doxorubicin—sarcoma	0.000293	0.000589	CcSEcCtD
Maprotiline—Nausea—Epirubicin—sarcoma	0.000284	0.000572	CcSEcCtD
Maprotiline—Vomiting—Doxorubicin—sarcoma	0.000281	0.000566	CcSEcCtD
Maprotiline—Rash—Doxorubicin—sarcoma	0.000279	0.000562	CcSEcCtD
Maprotiline—Dermatitis—Doxorubicin—sarcoma	0.000279	0.000561	CcSEcCtD
Maprotiline—Headache—Doxorubicin—sarcoma	0.000277	0.000558	CcSEcCtD
Maprotiline—Nausea—Doxorubicin—sarcoma	0.000263	0.000529	CcSEcCtD
Maprotiline—ABCB1—lymph node—sarcoma	0.000243	0.0029	CbGeAlD
